India Proposes Regulating Implants And Imaging Equipment As Drugs
Proposals to classify high-end medical devices as drugs are out for comment in India.
You may also be interested in...
A new FAQ document from India's health-care products regulator clarifies requirements relating to manufacturing licenses and other issues under the new medical device rules that came into effect on Jan. 1.
The Pink Sheet highlights recent comments and insights from pharma officials and executives on key issues we are covering.
The Pink Sheet's list of EU centralized approvals of new active substances has been updated to add six new products, including Genmab/AbbVie’s Tepkinly, for treating adult patients with relapsed or refractory diffuse large B-cell lymphoma after two or more lines of systemic therapy.